Anderson Hoagland & Co’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $234K | Sell |
446
-89
| -17% | -$46.7K | 0.02% | 141 |
|
|
2025
Q1 | $298K | Hold |
535
| – | – | 0.04% | 127 |
|
|
2024
Q4 | $365K | Sell |
535
-2,854
| -84% | -$1.95M | 0.04% | 126 |
|
|
2024
Q3 | $3.43M | Sell |
3,389
-100
| -3% | -$101K | 0.35% | 79 |
|
|
2024
Q2 | $3.68M | Hold |
3,489
| – | – | 0.39% | 67 |
|
|
2024
Q1 | $3.27M | Sell |
3,489
-1,566
| -31% | -$1.47M | 0.37% | 77 |
|
|
2023
Q4 | $4.74M | Sell |
5,055
-55
| -1% | -$51.6K | 0.58% | 48 |
|
|
2023
Q3 | $4.21M | Buy |
5,110
+2
| +0% | +$1.65K | 0.56% | 42 |
|
|
2023
Q2 | $3.67M | Hold |
5,108
| – | – | 0.47% | 49 |
|
|
2023
Q1 | $4.2M | Hold |
5,108
| – | – | 0.6% | 44 |
|
|
2022
Q4 | $3.66M | Buy |
5,108
+588
| +13% | +$421K | 0.53% | 50 |
|
|
2022
Q3 | $3.11M | Buy |
4,520
+16
| +0.4% | +$11K | 0.5% | 54 |
|
|
2022
Q2 | $2.74M | Hold |
4,504
| – | – | 0.41% | 60 |
|
|
2022
Q1 | $3.15M | Hold |
4,504
| – | – | 0.4% | 60 |
|
|
2021
Q4 | $2.8M | Buy |
4,504
+89
| +2% | +$55.3K | 0.37% | 70 |
|
|
2021
Q3 | $2.67M | Buy |
+4,415
| New | +$2.67M | 0.34% | 70 |
|
|
2021
Q1 | – | Sell |
-2,624
| Closed | -$1.27M | – | 112 |
|
|
2020
Q4 | $1.27M | Buy |
2,624
+1,074
| +69% | +$519K | 0.2% | 85 |
|
|
2020
Q3 | $967K | Sell |
1,550
-50
| -3% | -$31.2K | 0.46% | 57 |
|
|
2020
Q2 | $998K | Buy |
+1,600
| New | +$998K | 0.47% | 58 |
|
|
2017
Q1 | – | Sell |
-1,400
| Closed | -$514K | – | 109 |
|
|
2016
Q4 | $514K | Hold |
1,400
| – | – | 0.3% | 88 |
|
|
2016
Q3 | $563K | Hold |
1,400
| – | – | 0.32% | 85 |
|
|
2016
Q2 | $489K | Hold |
1,400
| – | – | 0.3% | 82 |
|
|
2016
Q1 | $505K | Buy |
+1,400
| New | +$505K | 0.31% | 73 |
|